T-MSIS provider-level spending data, Jan 2018 – Dec 2024
Inj., emicizumab-kxwh 0.5 mg
Total Paid
$247.0M
$247,040,460
Beneficiaries
8K
7,841
Avg $/Claim
$24,069
Utilization
1.3 claims/bene
11 providers
Each dot is a state. X = average cost per claim. Y = total spending.
Drag to zoom into a region